SCHEMBL316267

SCHEMBL316267

CC1CCNC(=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13186512 1.00
SCHEMBL7620002 1.00
SCHEMBL2483160 0.86
SCHEMBL7620666 0.86
Tert-Butyl Formate SCHEMBL27710947 0.80 TDP1 (0.42)
SCHEMBL4467181 0.78 CRBN (0.37)
SCHEMBL2042295 0.78
SCHEMBL14827803 0.78
SCHEMBL25324431 0.77 USP2 (0.32)
SCHEMBL10726202 0.75 OR51E2 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 392 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4423082-A1 CCR6 RECEPTOR MODULATORS Idorsia Pharmaceuticals Ltd (CH) 2024-09-04 EP claimed
WO-2023072924-A1 CCR6 RECEPTOR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2023-05-04 WO claimed
EP-3774310-A1 METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES Alcon Inc. (CH) 2021-02-17 EP claimed
CN-107254026-A Polymer and nano-gel material and its preparation and application 庄臣及庄臣视力保护公司 2017-10-17 CN claimed
WO-2017012963-A1 POLYMERIZABLE FATTY ACID-DERIVATIVE-MONOMERS WITH TERMINAL OLEFINIC DOUBLE BONDS, POLYMERS CONTAINING SAME MONOMERS, PRODUCTION AND USE THEREOF BASF SE (DE) 2017-01-26 WO claimed
US-20150024436-A1 SAMPLE PREPARATION, PROCESSING AND ANALYSIS SYSTEMS INTEGENX INC, (US) 2015-01-22 US claimed
WO-2013130910-A1 SAMPLE PREPARATION, PROCESSING AND ANALYSIS SYSTEMS INTEGENX INC. (US) 2013-09-06 WO claimed
US-7906556-B2 Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors ELAN PHARMACEUTICALS, INC. (US) 2011-03-15 US claimed
US-7858642-B2 Substituted hydroxyethylamine aspartyl protease inhibitors ELAN PHARMACEUTICALS, INC. (US) 2010-12-28 US claimed
EP-1638970-B1 PYRID (2, 1-A) - ISOQUINOLINE DERIVATIVES AS DPP-IV INHIBITORS HOFFMANN LA ROCHE (CH) 2010-11-24 EP claimed
US-20050239832-A1 Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitors ELAN PHARMACEUTICALS, INC. 2005-10-27 US claimed
US-20050239836-A1 Substituted hydroxyethylamine aspartyl protease inhibitors ELAN PHARMACEUTICALS, INC. 2005-10-27 US claimed
WO-2005087714-A2 METHODS OF TREATMENT OF AMYLOIDOSIS USING BI-CYCLIC ASPARTYL PROTEASE INHIBITORS ELAN PHARMACEUTICALS, INC. (US) 2005-09-22 WO claimed
WO-2005087751-A2 SUBSTITUTED HYDROXYETHYLAMINE ASPARTYL PROTEASE INHIBITORS ELAN PHARMACEUTICALS, INC. (US) 2005-09-22 WO claimed
WO-2005070407-A1 METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INIHIBITORS ELAN PHARMACEUTICALS, INC. (US) 2005-08-04 WO claimed
WO-2005000848-A1 PYRIDO` 2, 1-A - ISOQUINOLINE DERIVATIVES AS DPP-IV INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2005-01-06 WO claimed
US-20040259903-A1 Pyrido [2,1-a] isoquinoline derivatives F. HOFFMANN-LA ROCHE AG (CH) 2004-12-23 US claimed
EP-0366316-B1 Melt-processible aromatic polyamides DU PONT (US) 1994-12-07 EP claimed
US-5066445-A Recovery and melt extrusion of aromatic/aliphatic copolyamides from lactam-plasticized polymer E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-11-19 US claimed
EP-0366316-A1 Melt-processible aromatic polyamides E.I. DU PONT DE NEMOURS AND COMPANY (US) 1990-05-02 EP claimed